Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.

US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...

Mitchell Kapoor, an analyst from H.C. Wainwright, reiterated the Buy rating on Korro Bio (KRRO – Research Report). The associated price ...

The company says HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines ...

Want brighter skin? A rejuvenated complexion? A great deal? Then get over to Solawave and buy 1 age-defying kit and get ...

Research and development expense was $15.5 million for the third quarter of 2024, as compared to $7.6 million for the prior ...

Nevro (NYSE:NVRO) announced today that it received CE mark in Europe for its HFX iQ spinal cord stimulation (SCS) system.

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

Indapta Therapeutics, Inc., a privately held clinical stage biotechnology company developing next-generation differentiated cell therapies for the treatment of cancer and autoimmune diseases, today ...

Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional treatments. Accelerated over just five days, this therapy targets key brain areas ...